Aldehyde dehydrogenase 1A1 (ALDH1A1) expression by immunohistochemistry is associated with chemo-refractoriness in patients with high-grade ovarian serous carcinoma-Reference-Cited by-同舟云学术

Aldehyde dehydrogenase 1A1 (ALDH1A1) expression by immunohistochemistry is associated with chemo-refractoriness in patients with high-grade ovarian serous carcinoma

Published:2018-03 Issue: Volume:73 Page:1-6
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Roy Madhuchhanda,Connor Joseph,Al-Niaimi Ahmed,Rose Stephen L.,Mahajan Aparna

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference36 articles.

1. Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer;Bowtell;Nat Rev Cancer,2015

2. Optimal (≤1 cm) but visible residual disease: is extensive debulking warranted?;Barlin;Gynecol Oncol,2013

3. A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer;Suidan;Gynecol Oncol,2014

4. Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments;Kyrgiou;J Natl Cancer Inst,2006

5. First-line therapy for ovarian carcinoma: what's next?;Thigpen;Cancer Investig,2004

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative Analysis of Primary Ovarian Cancer Cells and Established Cell Lines as a New Tool for Studies on Ovarian Cancer Cell Complexity;International Journal of Molecular Sciences;2024-05-15

2. Selected markers of ovarian cancer and their relation to targeted therapy (Review);Experimental and Therapeutic Medicine;2024-03-27

3. The Role of Cancer Stem Cell Markers in Ovarian Cancer;Cancers;2023-12-20

4. Application of AlDeSense to Stratify Ovarian Cancer Cells Based on Aldehyde Dehydrogenase 1A1 Activity;Journal of Visualized Experiments;2023-03-31

5. Oct-4 induces cisplatin resistance and tumor stem cell-like properties in endometrial carcinoma cells;Taiwanese Journal of Obstetrics and Gynecology;2023-01